Polypeptide producing cells
AssigneeHoffmann-La Roche Inc.
InventorsJosef Endl, Erhard Kopetzki, Oliver Ploettner, Ursula Schwarz, Georg Tiefenthaler
Life of this patent
Estimating the term…
Abstract
The current invention describes a nucleic acid comprising in a 5′ to 3′ direction a) a first nucleic acid encoding a heterologous polypeptide without an in frame stop codon, b) a second nucleic acid beginning with a 5′ splice donor site and terminated by a 3′ splice acceptor site comprising an in frame translational stop codon and a polyadenylation signal, and c) a nucleic acid encoding i) at least a fragment of a transmembrane domain, or ii) a signal peptide for a GPI-anchor.
Claims1
A method for the production of a heterologous polypeptide or protein encoded by a nucleic acid, said method comprising;
- a) providing a eukaryotic cell,
- b) transfecting said eukaryotic cell with a nucleic acid, wherein the nucleic aid comprises in a 5′ to 3′ direction
- i) a first nucleic acid encoding an immunoglobulin heavy chain without an in frame stop codon at its 3′ terminus,
- ii) a second nucleic acid beginning with a 5′ splice donor site and terminated by a 3′ splice acceptor site comprising an in frame translational stop codon and a polyadenylation signal of a human or mouse immunoglobulin α, ε, γ and μ heavy chain, and
- iii) a third nucleic acid encoding at least 60% of a complete human immunoglobulin transmembrane stretch,
- wherein said immunoglobulin heavy chain and a marker are expressed from the same nucleic acid, wherein the marker is a plasma-membrane bound form of the expressed immunoglobulin heavy chain,
- c) culturing said transfected cell under conditions suitable for the expression of said nucleic acid, and
- d) recovering said polypeptide or protein from the culture medium or the cytoplasm of the cells.
Dependencies are inferred from the claim text.